In the very near future, you may visit your doctor and receive a drug therapy that was customized just for you based on your DNA, metabolism, and lifestyle. Advances in key technologies, including decoding the human genome (DNA), artificial intelligence (AI), and health information, are the catalysts for the rapidly accelerating field of personalized medicine. Navid Alipour, JD (Moderator) Co-founder and Managing Partner, Analytics Ventures Navid Alipour is Co-founder and Managing Partner at Analytics Ventures, a Venture Formation Fund focused on starting new ventures with artificial intelligence and machine learning at their core. Prior to co-founding Analytics Ventures, he founded La Costa Investment Group, making investments in startups nationally. Through the founding of multiple Artificial Intelligence(AI) based companies like CureMetrix and CureMatch, Navid is a long-time entrepreneur in the AI space, and looks to address the need between angel investors and big venture capital funds.

There's no shortage of tech entrepreneurs taking venture capital money to turn their artificial intelligence ideas into AI reality. These startups typically fill up at the VC spigot and go back to their offices to build product, with check-ins from the VC firm along the way. That's pretty much the complete opposite of the approach taken by Analytic Ventures. Analytic Ventures may look like your typical VC firm from the outside, but it's anything but on the inside. About a year and a half ago, the San Diego-based company created Analytic Ventures Fund 1, which sought cash from investors for the purpose of investing in startups that aimed to use AI tech to build products and services. But Analytic Ventures is anything but your run-of-the-mill VC firm.

Analytics Ventures is the only venture formation fund specialized in artificial intelligence, machine learning and Internet of Things.